Simon D. Roger

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Sodium Zirconium Cyclosilicate in Hyperkalemia

David Packham, Henrik Rasmussen, Philip T. Lavin et al. · New England Journal of Medicine · 2014 · 482 citations · Full text

Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt et al. · Kidney International · 2016 · 468 citations · Full text

Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Catherine M. Clase, Juan Jesús Carrero, David H. Ellison et al. · Kidney International · 2019 · 453 citations · Full text

Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis

Jill S. Lindberg, Bruce F. Culleton, Gordon Tin Chun Wong et al. · Journal of the American Society of Nephrology · 2005 · 407 citations